Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
Go back to Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update| Goss & De Leeuw Mach Co (NASDAQ: GOSS) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $0.00 | |||
| Open | $0.18 | 52 Week Low | $0.00 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $0.00 | |||
| Volume | 8,138,426 | |||||
